Healthcare systems worldwide confront a persistent and intensifying financial paradox: the accelerating pace of medical technology innovation creates continuous pressure to acquire advanced diagnostic and therapeutic equipment, yet capital budgets remain constrained by reimbursement headwinds, rising labor costs, and infrastructure demands. According to the American Hospital Association, U.S. hospitals absorbed approximately $130 billion in Medicare and Medicaid underpayments in 2023 while simultaneously spending $146.9 billion on capital equipment and technology investments . This structural imbalance has elevated the used medical equipment and parts market from a niche alternative to a strategic procurement imperative, enabling healthcare providers to access essential technology at 40% to 60% below comparable new equipment pricing while maintaining clinical performance standards .
The broader refurbished medical equipment ecosystem has demonstrated remarkable growth, with independent market analyses valuing the sector at approximately $23.59 billion in 2025, projected to reach $39.52 billion by 2032 at a 7.64% CAGR . Within this expansive landscape, QYResearch’s focused analysis of used medical equipment and parts reveals that this specific segment was valued at approximately US$ 6,697 million in 2025 and is projected to reach US$ 9,135 million by 2032, expanding at a Compound Annual Growth Rate (CAGR) of 4.6% during the forecast period spanning 2026 to 2032.
Used medical equipment and parts refers to healthcare apparatus and components that have been previously owned, utilized, or refurbished, rather than being brand new from the manufacturer. This category encompasses a vast range of items—from large, complex machinery like MRI scanners, CT machines, and operating room tables to smaller, more common devices such as patient monitors, infusion pumps, and surgical instruments. It also includes individual parts and accessories necessary for the repair, maintenance, or upgrading of existing medical devices, such as circuit boards, power supplies, sensors, and specialized tools. The market for used medical equipment and parts is significant due to several factors: it offers a more cost-effective solution for healthcare providers, especially those in developing regions or with limited budgets, enabling them to acquire essential technology at a fraction of the original price. Furthermore, it supports sustainability by extending the lifespan of valuable equipment and reducing electronic waste—a critical consideration given that healthcare contributes nearly 5% of global greenhouse gas emissions .
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6088430/used-medical-equipment-and-parts
Market Dynamics: The Structural Drivers of 4.6% CAGR Expansion
The Used Medical Equipment and Parts market’s 4.6% CAGR projection is underpinned by converging financial, technological, and regulatory forces that are fundamentally reshaping healthcare procurement strategies globally.
Cost Containment and Capital Efficiency: The most enduring driver remains the substantial cost advantage of refurbished medical devices relative to new equipment acquisitions. Certified refurbished imaging systems, surgical equipment, and patient monitoring devices typically command pricing 40% to 60% below comparable new units, enabling healthcare providers—particularly community hospitals, ambulatory surgery centers, and facilities in emerging economies—to access advanced technology without compromising financial sustainability . This value proposition has gained particular salience as hospitals navigate persistent Medicare and Medicaid underpayment challenges while maintaining essential capital investment programs.
Sustainability and Circular Economy Mandates: Environmental considerations have transitioned from peripheral corporate social responsibility initiatives to central procurement criteria. More than 70% of large U.S. hospital systems now identify sustainability as a top organizational priority, and the European Union’s Corporate Sustainability Reporting Directive (CSRD), implemented in July 2024, requires large companies to disclose supply chain environmental performance, adding formal accountability to healthcare purchasing decisions . Used medical equipment procurement demonstrably reduces carbon footprint by extending device lifecycles and diverting functional equipment from landfill disposal, aligning clinical operations with increasingly stringent environmental governance requirements.
AI Integration and Technological Parity: The refurbished equipment landscape has been fundamentally transformed by the integration of artificial intelligence capabilities. The FDA cleared 107 AI/ML medical devices in 2024, up from just six in 2014, with radiology accounting for 76% of all approvals . Given that imaging equipment constitutes approximately 38.9% of the refurbished market share, the overlap between AI-enabled diagnostics and secondary market equipment is explicit and expanding—approximately 39% of refurbished diagnostic systems now incorporate AI tools, positioning used medical equipment as a viable pathway to accessing advanced diagnostic capabilities without premium new-equipment pricing .
Tariff Impacts and Supply Chain Reconfiguration: The introduction of heightened U.S. tariffs in 2025 on imported refurbished medical equipment and components has introduced significant complexity to cross-border trade dynamics. Increased duties on select imaging equipment, including CT scanners and MRI machines, have elevated landed costs and compelled stakeholders to reevaluate sourcing strategies . In response, industry participants are accelerating investments in regional service hubs and domestic refurbishment facilities to mitigate tariff exposure while maintaining competitive pricing. This strategic shift is fostering a more localized and agile supply chain architecture, with partnerships between original equipment manufacturers and independent refurbishers becoming increasingly prevalent .
Regulatory Harmonization and Quality Assurance: Evolving regulatory frameworks across major jurisdictions have elevated quality and safety standards for refurbished medical devices. Initiatives to harmonize certification requirements and introduce stringent quality audits have reinforced stakeholder confidence in reconditioned equipment, enabling deployment within critical care environments including operating rooms and intensive care units. However, the trade and use of such items remain subject to strict regulations to ensure safety, functionality, and compliance with health standards, often requiring thorough inspection, cleaning, calibration, and certification before resale.
Technology Architecture and Product Segmentation
The Used Medical Equipment and Parts market encompasses a diverse portfolio of product categories, each exhibiting distinct demand dynamics and refurbishment complexity:
Medical Imaging Equipment: Represents the largest and most active segment, driven by the substantial capital investment required for new MRI, CT, ultrasound, and X-ray systems. Imaging equipment is capital-intensive when purchased new, making it highly attractive in refurbished form. Ultrasound systems offer particular value due to broad specialty applications, compact installation requirements, and strong ROI for outpatient facilities . Mid-tier CT and MRI systems maintain robust demand in emerging markets where cost sensitivity is pronounced.
Operating Room and Surgical Equipment: Encompasses surgical tables, surgical lights, anesthesia machines, electrosurgical units, and patient warming systems. Ambulatory surgery centers (ASCs) frequently purchase refurbished OR packages when opening new facilities, creating bundling opportunities for vendors that improve average order value and strengthen customer relationships .
Patient Monitoring Systems: Multiparameter monitors and telemetry systems maintain consistent resale demand driven by replacement of aging units, expansion of outpatient surgical centers, emergency department growth, and international hospital upgrades. Monitoring systems offer relatively fast refurbishment turnaround and predictable resale cycles .
Cardiovascular and Cardiology Equipment: Refurbished defibrillators, EKG/ECG systems, and cardiac monitors see rapid adoption in high-volume cardiac care units, where reliability and cost-efficiency are paramount.
Endoscopy Equipment: Complete endoscopy towers—including processors, light sources, scopes, and monitors—offer strong resale margins when properly refurbished, driven by GI procedure growth and outpatient center expansion .
IV Therapy Systems and Neurology Equipment: Represent steady-demand categories supporting essential clinical workflows across hospital and outpatient settings.
The market can also be disaggregated by end-user channel:
Hospitals: The dominant volume segment, leveraging secondary market acquisitions to alleviate budget constraints and extend equipment lifecycles.
Clinics: Outpatient facilities and specialty clinics seeking cost-effective access to advanced diagnostic and therapeutic technology.
Others: Ambulatory surgery centers, diagnostic imaging centers, research institutions, and home care settings.
Competitive Ecosystem and Strategic Positioning
The Used Medical Equipment and Parts market exhibits a heterogeneous competitive landscape encompassing original equipment manufacturers (OEMs) with dedicated refurbishment divisions, specialized independent refurbishers, and emerging technology-enabled platforms. Key participants profiled within this analysis include GE Healthcare, Siemens Healthcare, Philips Healthcare, Ultra Solutions, Agito Medical, Soma Technology, Block Imaging, Whittemore Enterprises, Radiology Oncology Systems, Integrity Medical Systems, and TRACO.
Leading OEMs—including GE Healthcare, Siemens Healthineers, and Philips Healthcare—have established proprietary refurbishment programs that leverage original design expertise to deliver certified reconditioned systems. GE Healthcare’s April 2024 launch of an A1 SURE Ultrasound Systems refurbishment center in Bangladesh exemplifies this strategic approach, supplying high-quality, affordable aftermarket ultrasound equipment to hospitals and diagnostic centers while providing warranty and service support comparable to new systems . Similarly, strategic collaborations between OEMs and technology providers—such as the March 2025 GE HealthCare and NVIDIA partnership to build autonomous imaging technology—underscore the convergence of refurbished equipment with advanced AI capabilities .
Independent refurbishment specialists differentiate through operational agility, specialized technical expertise, and responsive customization capabilities. These providers have developed robust accreditation processes and deep technical capabilities to recondition equipment across multiple categories, maintaining strong relationships with hospitals and clinics seeking to minimize service disruptions.
Exclusive Industry Observation: The AI-Enabled Refurbishment Transformation
A critical but underappreciated dimension of the Used Medical Equipment and Parts market concerns the integration of artificial intelligence and digital connectivity into refurbished systems. The convergence of AI-enabled diagnostics with certified refurbished imaging platforms represents a paradigm shift: refurbished equipment is no longer positioned as a cost-substitute for legacy technology but rather as a viable pathway to accessing advanced diagnostic capabilities. As healthcare systems increasingly prioritize digital integration and predictive analytics, refurbished devices equipped with connectivity-enabled features and AI toolkits offer compelling value propositions that extend beyond initial acquisition economics.
Furthermore, the emergence of outcome-based service models —performance-based agreements linking revenue to equipment uptime and clinical outcomes—is reshaping vendor-provider relationships. These arrangements are particularly prevalent in cardiology and oncology applications, where device reliability directly influences patient throughput. Providers that integrate advanced diagnostics, remote monitoring capabilities, and performance-based agreements are positioned to capture disproportionate market share.
Strategic Outlook and Investment Implications
Looking toward the 2032 horizon, the Used Medical Equipment and Parts market is positioned for sustained expansion as healthcare systems globally prioritize cost efficiency, sustainability, and technology access. The 4.6% CAGR projection reflects durable demand for refurbished medical equipment that addresses the fundamental capital constraints facing healthcare providers while enabling access to advanced diagnostic and therapeutic capabilities.
For healthcare administrators, procurement leaders, and medical equipment investors, several actionable imperatives emerge. First, certified refurbishment programs from OEMs and accredited independent providers should be prioritized over uncertified alternatives to ensure clinical performance, regulatory compliance, and warranty protection. Second, AI-enabled diagnostic systems within the refurbished equipment segment represent a high-value opportunity to access advanced capabilities without premium new-equipment pricing—particularly in imaging modalities where AI integration is most mature. Third, supply chain diversification strategies should account for evolving tariff structures and prioritize regional refurbishment partnerships that reduce exposure to cross-border trade volatility.
The convergence of persistent healthcare capital constraints, accelerating AI integration, and intensifying sustainability mandates establishes a durable foundation for continued investment in Used Medical Equipment and Parts through 2032 and beyond.
Market Segmentation Reference:
By Type:
Medical Imaging Equipment
Operating Room and Surgical Equipment
Monitoring Equipment
Defibrillators
Cardiovascular and Cardiology Equipment
IV Therapy Systems
Neurology Equipment
Endoscopy Equipment
Others
By Application:
Hospital
Clinic
Others
Key Market Participants:
GE Healthcare, Siemens Healthcare, Philips Healthcare, Ultra Solutions, Agito Medical, Soma Technology, Block Imaging, Whittemore Enterprises, Radiology Oncology Systems, Integrity Medical Systems, TRACO.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
